Role of nitric oxide synthase in collagen-platelet interaction: Involvement of platelet nonintegrin collagen receptor nitrotyrosylation

Thrombosis Research

Volumn 102, Issue 4, 2001, Pages 343-352

  Chiang, Thomas M ^a   Cole, Flecia ^a   Woo Rasberry, Virginia ^a   Kang, Ellen S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Collagen; Nitric oxide synthase; Platelet; Platelet aggregation; Platelet aggregation inhibitor; Receptor

Indexed keywords

COLLAGEN TYPE 1; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POLYCLONAL ANTIBODY; PROTEIN; RECOMBINANT PROTEIN; THROMBOCYTE RECEPTOR;

ARTICLE; ENDOTHELIUM; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

BLOOD PLATELETS; BLOOD PROTEINS; COLLAGEN; HUMANS; INTEGRINS; KINETICS; MOLECULAR WEIGHT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PLACENTA; PLATELET AGGREGATION; RECEPTORS, COLLAGEN; RECOMBINANT PROTEINS; TYROSINE;

EID: 0035874001     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00252-3     Document Type: Article

References (46)

1. Radomski MW, Palmer RM, Moncada S Characterization of the L-arginine: nitric oxide pathway in human platelets. Br J Pharmacol. 101:1990;325-328.
2. Radomski MW, Palmer RMJ, Moncada S An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A. 87:1990;5193-5197.
3. Pronai L, Ichimori K, Nozaki H, Nakazawa H, Okino H, Carmichael AJ, Arroyo CM Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies. Eur J Biochem. 202:1991;923-930.
4. Cadwgan TM, Benjamin N Evidence for altered platelet nitric oxide synthesis in essential hypertension. J Hypertens. 11:1993;417-420.
5. Vasta V, Meacci GC, Farnararo M, Bruni P Identification of a specific transport system for L-arginine in human platelets. Biochem Biophys Res Commun. 206:1995;878-884.
6. Chen LY, Mehta JL Downregulation of nitric oxide synthase activity in human platelets by nitroglycerin and authentic nitric oxide. J Invest Med. 45:1997;69-74.
7. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 100:1997;350-356.
8. Franconi F, Miceli M, Alberti L, Seghieri G, De Montis MG, Tagliamonte A Further insights into the anti-aggregating activity of NMDA in human platelets. Br J Pharmacol. 124:1998;35-40.
9. Chiang TM, Jin A, Kang AH Collagen platelet interaction: inhibition by a monoclonal antibody raised against the platelet collagen receptor. J Immunol. 139:1987;887-892.
10. Chiang TM, Rinaldy A, Kang AH Cloning, characterization, and functional studies of a platelet receptor for type I collagen. J Clin Invest. 100:1997;514-521.
11. Chiang TM, Kang AH A synthetic peptide derived from the sequence of type I collagen receptor inhibits type I collagen-mediated platelet aggregation. J Clin Invest. 100:1997;2079-2084.
12. Pool A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JGJ, Saito T, Tybulewicz VLJ, Watson SP The Fc receptor-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 16:1997;2333-2341.
13. Xia Y, Dawson V, Dawson T, Snyder S, Zweier J Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A. 93:1996;6770-6774.
14. Beckman J, Koppenol W Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 271:1996;C1424-C1437.
15. Peire MA, Puig-Parallada P Oxygen-free radicals and nitric oxide are involved in the thrombus growth produced by iontophoresis of ADP. Pharmacol Res. 38:1998;353-356.
16. Wade M, Fitzpatrick FA Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase. Arch Biochem Biophys. 347:1997;174-180.
17. Chiang TM, Kang AH Isolation and purification of α1(I) receptor from human platelet membrane. J Biol Chem. 257:1982;7581-7586.
18. Chiang TM Phosphorylation-dephosphorylation states at different sites affect phosphoprotein phosphatase 1 activity. Thromb Res. 92:1998;233-238.
19. Chiang TM, Wang Y, Kang ES Role of the recombinant protein of the platelet receptor for type I collagen in the release of nitric oxide during platelet aggregation. Thromb Res. 100:2000;427-432.
20. Chiang TM, Beachey EH, Kang AH Interaction of a chick skin collagen fragment (α1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction. J Biol Chem. 250:1976;6916-6922.
21. Seyer JM, Hutchesion ET, Kang AH Collagen polymorphism in idiopathic chronic pulmonary fibrosis. J Clin Invest. 57:1976;1498-1507.
22. Bergman I, Loxley R Two improved and simplified methods for spectrophotometeric determination of hydroxyproline. Anal Chem. 35:1963;1961-1965.
23. Chiang TM A synthetic nonapeptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation. Am J Med Sci. 320:2000;362-367.
24. Born GVR Aggregation of platelets by adenosine diphosphate and its reversal. Nature. 194:1962;927-929.
25. Chiang TM, Wang Y, Kang ES Effect of recombinant protein of the platelet receptor for type I collagen on nitric oxide release during platelet aggregation. Thromb Res. 100:2000;427-432.
26. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Spiecker M, Darius H, Meyer J Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo. Thromb Res. 70:1993;405-415.
28. de Groot H, Hegi U, Sies H Losee of alpha-tocopherol upon exposure to nitric oxide or the sydnonimine SIN-1. FEBS Lett. 315:1993;139-142.
29. Mondoro TH, Shafer BC, Vostal JG Peroxynitrite-induced tyrosine nitration and phosphorylation in human platelets. Free Radical Biol Med. 22:1997;1055-1063.
30. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, Violi F Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide. Arterioscler, Thromb, Vasc Biol. 19:1999;2542-2547.
31. Zhang J, Patel J, Li Y, Block E Reductase domain cysteines 1048 and 1114 are critical for catalytic activity of human endothelial cell nitric oxide synthase as probed by site-directed mutagenesis. Biochem Biophys Res Commun. 226:1996;293-300.
32. Bredt DS, Ferris CD, Snyder SH Nitric oxide synthase regulatory sites: phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase, identification of flavin and calmodulin binding sites. J Biol Chem. 267:1992;10976-10981.
33. Bode-Boger SM, Boger RH, Galland A, Frolich JC Differential inhibition of human platelet aggregation and thromboxane B2 formation by L-arginine in vivo and in vitro. Naunyn-Schmiedeberg's Arch Pharmacol. 357:1998;143-150.
34. Kunicki TJ, Nugent DJ, Staatz SJ, Okchekowski RP, Wayner EA, Carter WG The human fibroblast class II extracellular matrix receptor mediates platelet adhesion to collagen and it's identical to the platelet GPIa-IIa complex. J Biol Chem. 263:1988;4516-4519.
35. 2+-dependent adhesion of platelets to collagen. J Cell Biol. 108:1989;1017-1024.
36. Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ Human blood platelets showing no response to collagen fail to express surface glycoprotein 1b. Nature. 318:1985;470-472.
37. Jiang H, Balazy M Detection of 3-nitrotyrosine in human platelets exposed to peroxynitrite by a new gas chromatography/mass spectrometry assay. Nitric Oxide. 2:1998;350-359.
38. Kehrel B, Balleisen L, Kokott R, Mesters R, Stenzinger W, Clemetson KJ, van de Loo J Deficiency of thrombospondin and membrane glycoprotein 1a in platelet with defective collagen-induced platelet aggregation and spontaneous loss of disorder. Blood. 71:1988;1074-1078.
39. Chiang TM Collagen-platelet interaction: platelet non-integrin receptors. Histol Histopathol. 14:1999;579-585.
40. Ichinohe T, Takayama H, Ezumi Y, Arai M, Yamamoto N, Takahashi H, Okuma M Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelet lacking membrane glycoprotein VI. J Biol Chem. 272:1997;63-68.
41. Inoue K, Ozaki Y, Satoh K, Wu Y, Yatomi Y, Shin Y, Morita T Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI. Biochem Biophys Res Commun. 256:1999;114-120.
42. Francischetti IMB, Chiang TM, Guimaraes JA, Bon C Effects of the recombinant non-integrin platelet collagen receptor, P65, on platelet activation induced by convulxin. Biochem Biophys Res Commun. 270:2000;932-935.
43. Patel J, Block E Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 13:1995;352-359.
44. Mallozzi C, Di Stasi AMM, Minetti M Activation of src tyrosine kinases by peroxynitrite. FEBS Lett. 456:1999;201-206.
45. Patel J, Zhang J, Block E Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am J Respir Cell Mol Biol. 15:1996;410-419.
46. Lamas S, Marsden P, Li G, Tempst P, Michel T Endothelial nitric oxide synthase molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 89:1992;6348-6352.